Fcf Advisors LLC Pfizer Inc Transaction History

Fcf Advisors LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 19, 2023	SELL	$36.12 - $41.79 $1.12 Million - $1.3 Million	-30,996 Reduced 96.77%	1,033 $37,000
Q1 2023 Apr 19, 2023	SELL	$39.39 - $51.28 $369,044 - $480,442	-9,369 Reduced 22.63%	32,029 $1.31 Million
Q4 2022 Feb 03, 2023	SELL	$41.75 - $54.5 $38,952 - $50,848	-933 Reduced 2.2%	41,398 $2.12 Million
Q3 2022 Oct 12, 2022	SELL	$43.76 - $53.42 $407,143 - $497,019	-9,304 Reduced 18.02%	42,331 $1.85 Million
Q2 2022 Jul 20, 2022	SELL	$46.53 - $55.17 $2.15 Million - $2.55 Million	-46,227 Reduced 47.24%	51,635 $2.71 Million
Q1 2022 Apr 28, 2022	BUY	$45.75 - $56.69 $2.08 Million - $2.58 Million	45,516 Added 86.95%	97,862 $5.07 Million
Q4 2021 Jan 10, 2022	BUY	$41.32 - $61.25 $2.16 Million - $3.21 Million	52,346 New	52,346 $3.09 Million

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Fcf Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Fcf Advisors LLC with notifications on news.